Cannabis Science Major Shareholder Sells $22,126 in Stock (CBIS)
Cannabis Science (NASDAQ:CBIS) major shareholder Robert Melamede sold 170,200 shares of the stock in a transaction that occurred on Thursday, January 9th. The shares were sold at an average price of $0.13, for a total value of $22,126.00. Following the completion of the sale, the insider now directly owns 49,954,633 shares of the company’s stock, valued at approximately $6,494,102. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.
Shares of Cannabis Science (NASDAQ:CBIS) traded down 20.82% during mid-day trading on Friday, hitting $0.1164. The stock had a trading volume of 85,667,584 shares. Cannabis Science has a 52-week low of $0.033 and a 52-week high of $0.12. The stock has a 50-day moving average of $0.04 and a 200-day moving average of $0.04. The company’s market cap is $88.6 million.
Cannabis Science, Inc is a development-stage company. Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.